Recruiting
Hepatic cancer
RecruitingEvaluating the use of technetium (99mTc) galactosyl serum albumin to predict complications in patients undergoing surgery for liver tumors
InvestigationalNo placebo
Evaluating the use of technetium (99mTc) galactosyl serum albumin to predict complications in patients undergoing surgery for liver tumors
InvestigationalNo placebo
- Disease:Hepatic cancer
- Substances:Technetium (99MTC) galactosyl serum albumin
Countries:
Denmark
Denmark- Participants:18–64 years · 65+ years
- Substances:Technetium (99MTC) galactosyl serum albumin
